Saturday, March 08, 2014
Go to Market Reports.com
Composite Profiling of Angiogenic Factors Using Bio-Plex Pro Human Can
High Speed, High Volume Laboratory Network for Infectious Diseases and
Speeding up time-to-market
Vetter Pharma International GmbH
Stellaris RNA FISH: Detection, Localization, and Quantification of mRN
Biosearch Technologies Inc.
White Paper on Promoting Integrity in Scientific Journal Publications
The council of Science Editors
showing results 1 to 5 of 5
NexImmune’s AIM™ Technology Enables Novel Adoptive Immunotherapy Approach for Cancer Treatment
New scientific publication by NexImmune co-founder Dr. Jonathan Schneck.
A Crisper View of DNA-Snipping Enzyme
HHMI scientists have created a portrait of a DNA-snipping protein called Cas9, a powerful research tool used in many labs for genome editing.
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Weapon Fights Drug-Resistant Tumors
A new study from MIT reveals a way to combat recurrent tumors with a drug that makes them more vulnerable to the antibody treatment.
Antibiotic ‘Smart Bomb’ Can Target Specific Strains of Bacteria
Technique offers a potential approach to treat infections by multi-drug resistant bacteria.
Toxin Kills HIV-Infected Cells
An HIV-specific poison can kill cells in which the virus is still reproducing despite antiretroviral therapy, a study in mice showed.
NIAID Study Identifies Immune Sensors of Malnutrition
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases.
Tricky Protein May Help HIV Vaccine Development
Researchers have determined the structure of a key part of the HIV envelope protein, the gp41 membrane proximal external region, which previously eluded detailed structural description.
Arthritis Genetics Analysis Aids Drug Discovery
Researchers identify 42 new areas in the human genome associated with rheumatoid arthritis, many of which are already the targets of drugs approved for other conditions.
New Clues to How Bacteria Evade Antibiotics
Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics.
Advertise On This Site
Terms & Conditions
©2014 Technology Networks
, all rights reserved.